{
  "ticker": "OSX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968852",
  "id": "02968852",
  "pages": 3,
  "price_sensitive": true,
  "date": "20250714",
  "time": "0825",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrpl0gdz4qpr.pdf",
  "summary": "- **Regulatory Approval**: Osteopore (ASX: OSX) secures Swiss market approval under EU Medical Device Regulation (MDR) for its off-the-shelf and custom-made implants.  \n- **Strategic Impact**: Completes product portfolio for European market entry, bolstered by existing partnership with Zimmer Biomet (distribution in EMEA, APAC, Australia, NZ).  \n- **Market Opportunity**: European cranial implant market projected to reach **USD527.6 million by 2027**, with custom implants as the largest segment.  \n\n**No trading or capital-raising details identified.**  \n\n*(Note: Excluded forward-looking statements, operational background, and CEO commentary as non-material to immediate trading decisions.)*",
  "usage": {
    "prompt_tokens": 1567,
    "completion_tokens": 146,
    "total_tokens": 1713,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-13T22:47:54.511569"
}